Next Article in Journal
Corticosteroid Treatment in Airways Narrowing
Previous Article in Journal
Mycobacterial Infection Caused by Mycobacterium avium in Allogenic Bone Marrow Transplant Recipient with Concomittant Bronchiolitis Obliterans as a Manifestation of Graft Versus Host Disease—Case Report and Review of the Literature
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Interstitial Pneumonitis in a Patient Treated with Amiodarone—Case Report

by
Anna Paczek
1,*,
Monika Szturmowicz
1,
Elżbieta Wiatr
2,
Barbara Burakowska
3,
Anna Fijałkowska
1 and
Adam Torbicki
1
1
Klinika Chorób Wewnętrznych Klatki Piersiowej Instytutu Gruźlicy i Chorób Płuc w Warszawie, 01-138 Warszawa, Poland
2
III Klinika Chorób Płuc Instytutu Gruźlicy i Chorób Płuc w Warszawie, 01-138 Warszawa, Poland
3
Zakład Radiologii Instytutu Gruźlicy i Chorób Płuc w Warszawie, 01-138 Warszawa, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2008, 76(2), 118-124; https://doi.org/10.5603/ARM.27917
Submission received: 23 July 2007 / Revised: 28 April 2008 / Accepted: 28 April 2008 / Published: 28 April 2008

Abstract

Amiodarone, antiarrhythmic drug of III class is used in patients with supraventricular and ventricular arrhythmias, often with coexisting congestive heart failure. Side effects of amiodarone treatment are observed in approximately 75% of patients. Most dangerous are the symptoms of amiodarone pulmonary toxicity occuring in 2–17% of patients. We present a patient with COPD, in whom interstitial pneumonitis with radiologic features of organizing pneumonia developed after one year of amiodaron treatment due to supraventricular and ventricular arrhythmias. The drug was stopped and steroids were introduced due to marked respiratory insufficiency. Regression of pulmonary symptoms and improvement of ventilatory parameters were observed after 3 months of treatment. Pathogenesis, diagnostic procedures and current methods of treatment of this jatrogenic disease are discussed.
Keywords: amiodarone; organizing pneumonia; steroidotherapy amiodarone; organizing pneumonia; steroidotherapy

Share and Cite

MDPI and ACS Style

Paczek, A.; Szturmowicz, M.; Wiatr, E.; Burakowska, B.; Fijałkowska, A.; Torbicki, A. Interstitial Pneumonitis in a Patient Treated with Amiodarone—Case Report. Adv. Respir. Med. 2008, 76, 118-124. https://doi.org/10.5603/ARM.27917

AMA Style

Paczek A, Szturmowicz M, Wiatr E, Burakowska B, Fijałkowska A, Torbicki A. Interstitial Pneumonitis in a Patient Treated with Amiodarone—Case Report. Advances in Respiratory Medicine. 2008; 76(2):118-124. https://doi.org/10.5603/ARM.27917

Chicago/Turabian Style

Paczek, Anna, Monika Szturmowicz, Elżbieta Wiatr, Barbara Burakowska, Anna Fijałkowska, and Adam Torbicki. 2008. "Interstitial Pneumonitis in a Patient Treated with Amiodarone—Case Report" Advances in Respiratory Medicine 76, no. 2: 118-124. https://doi.org/10.5603/ARM.27917

Article Metrics

Back to TopTop